Skip to main content

Table 5 Acyl chain length of each lipid class after different doses of γ-ray treatment in WS, PLDδ-deficient (def), Col and PLDα1-def plants

From: Profiling membrane glycerolipids during γ-ray-induced membrane injury

Lipid speciesGenotypeDose of gamma irradiation (Gy)
0462101100
Acyl chain length
DGDGWS35.46 ± 0.02bA35.44 ± 0.04bcA35.41 ± 0.02cB35.61 ± 0.02aA
PLDδ-def35.42 ± 0.01bAB35.40 ± 0.03bA35.40 ± 0.05bB35.54 ± 0.05aB
Col35.42 ± 0.06bAB35.39 ± 0.03bA35.41 ± 0.02bB35.64 ± 0.04aA
PLDα1-def35.40 ± 0.03cB35.41 ± 0.06cA35.47 ± 0.02bA35.62 ± 0.03aA
MGDGWS34.32 ± 0.04bA34.35 ± 0.06bA34.36 ± 0.09bAB34.50 ± 0.07aAB
PLDδ-def34.25 ± 0.02cB34.26 ± 0.04bcA34.34 ± 0.08abB34.42 ± 0.08aB
Col34.25 ± 0.06cB34.36 ± 0.18bcA34.45 ± 0.15abAB34.55 ± 0.12aA
PLDα1-def34.24 ± 0.04cB34.39 ± 0.20bcA34.48 ± 0.06abA34.56 ± 0.09aA
PGWS33.86 ± 0.01aB33.85 ± 0.02aB33.88 ± 0.03aA33.78 ± 0.03bA
PLDδ-def33.90 ± 0.02aA33.89 ± 0.03aA33.88 ± 0.03aA33.82 ± 0.03bA
Col33.91 ± 0.02aA33.91 ± 0.03aA33.86 ± 0.02bAB33.78 ± 0.03cA
PLDα1-def33.93 ± 0.03aA33.90 ± 0.03aA33.83 ± 0.02bB33.66 ± 0.06cB
PAWS34.44 ± 0.11abAB34.46 ± 0.17abAB34.61 ± 0.17aAB34.29 ± 0.26bC
PLDδ-def34.31 ± 0.20aB34.32 ± 0.16aB34.29 ± 0.22aB34.52 ± 0.16aBC
Col34.59 ± 0.17aA34.67 ± 0.26aB34.68 ± 0.29aAB34.79 ± 0.23aA
PLDα1-def34.66 ± 0.30aA34.94 ± 0.64aA34.83 ± 0.54aA34.63 ± 0.06aAB
PCWS35.05 ± 0.05bA35.01 ± 0.03bA35.19 ± 0.04aA35.14 ± 0.04aA
PLDδ-def35.18 ± 0.08abA35.13 ± 0.04bA35.25 ± 0.04aAB35.16 ± 0.06bA
Col35.10 ± 0.17aA35.10 ± 0.12aA35.02 ± 0.17aC35.05 ± 0.07aA
PLDα1-def35.08 ± 0.17abA35.00 ± 0.22abA35.11 ± 0.03aBC34.89 ± 0.15bB
PEWS35.12 ± 0.05bB35.11 ± 0.02bB35.32 ± 0.05aA35.17 ± 0.05bA
PLDδ-def35.21 ± 0.08abA35.17 ± 0.03bA35.29 ± 0.03aA35.20 ± 0.09bA
Col35.17 ± 0.04bAB35.18 ± 0.02bA35.24 ± 0.02aB35.17 ± 0.04bA
PLDα1-def35.19 ± 0.04aA35.20 ± 0.05aA35.23 ± 0.03aB35.19 ± 0.07aA
PIWS34.13 ± 0.01aC34.12 ± 0.02abB34.11 ± 0.02bAB34.11 ± 0.01abA
PLDδ-def34.15 ± 0.02aBC34.13 ± 0.02aB34.14 ± 0.06aA34.11 ± 0.01aA
Col34.18 ± 0.04aAB34.21 ± 0.05aA34.09 ± 0.03bB34.08 ± 0.02bB
PLDα1-def34.20 ± 0.01aA34.18 ± 0.04aA34.11 ± 0.01bAB34.07 ± 0.04cB
PSWS40.47 ± 0.17bA40.79 ± 0.12aA40.97 ± 0.18aA40.83 ± 0.25aB
PLDδ-def40.31 ± 0.20cA40.55 ± 0.15bA40.88 ± 0.12aA41.00 ± 0.20aAB
Col39.62 ± 0.47bB39.98 ± 0.40bB40.72 ± 0.37aA41.07 ± 0.35aAB
PLDα1-def39.78 ± 0.55bB39.64 ± 0.49bB40.72 ± 0.39aA41.33 ± 0.48aA
TotalWS34.58 ± 0.04bA34.61 ± 0.05bA34.65 ± 0.09bAB34.82 ± 0.05aAB
PLDδ-def34.51 ± 0.02cAB34.52 ± 0.07cA34.63 ± 0.09bB34.78 ± 0.07aB
Col34.48 ± 0.09cB34.57 ± 0.13bcA34.68 ± 0.10bAB34.84 ± 0.03aAB
PLDα1-def34.48 ± 0.06cB34.59 ± 0.16cA34.74 ± 0.03bA34.88 ± 0.07aA
  1. Different lowercase letters marked in the same row represent significantly different among different γ-ray treatments. Different uppercase letters marked in the same column represent significantly different among different genotypes, (p < 0.05). Data are means ± standard deviation (n = 4 or 5)